Total Payments
$719.82
2024 Payments
$431.91
Companies
10
Transactions
14
Medicare Patients
779
Medicare Billing
$30,688
Payment Breakdown by Category
Food & Beverage$719.82 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $719.82 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $239.66 | 2 | $0 (2024) |
| Amgen Inc. | $121.88 | 1 | $0 (2023) |
| Lilly USA, LLC | $121.50 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $54.12 | 2 | $0 (2024) |
| Organon LLC | $47.73 | 1 | $0 (2022) |
| Abbott Laboratories | $46.50 | 2 | $0 (2020) |
| Merck Sharp & Dohme LLC | $30.57 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.84 | 1 | $0 (2022) |
| Cranial Technologies, Inc | $17.39 | 1 | $0 (2023) |
| Novo Nordisk Inc | $16.63 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $431.91 | 6 | AstraZeneca Pharmaceuticals LP ($239.66) |
| 2023 | $152.23 | 3 | Amgen Inc. ($121.88) |
| 2022 | $89.18 | 3 | Organon LLC ($47.73) |
| 2020 | $46.50 | 2 | Abbott Laboratories ($46.50) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.63 | General |
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.50 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: Inflammation | ||||||
| 02/16/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/04/2023 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Cranial Orthotic | ||||||
| 12/02/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $47.73 | General |
| Category: ETONOGESTREL | ||||||
| 10/13/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: VACCINE | ||||||
| 09/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: DIABETES | ||||||
| 05/15/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/29/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 19 | $2,770 | $1,331 |
| 2022 | 3 | 41 | 41 | $5,245 | $1,594 |
| 2021 | 12 | 379 | 391 | $34,150 | $12,990 |
| 2020 | 11 | 344 | 360 | $36,472 | $14,772 |
Total Patients
779
Total Services
811
Medicare Billing
$30,688
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 19 | $2,770 | $1,331 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $4,296 | $1,382 | 32.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 12 | 12 | $564.00 | $126.61 | 22.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 11 | 11 | $385.00 | $85.39 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 72 | $14,468 | $6,062 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 55 | $7,390 | $3,058 | 41.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 34 | 34 | $2,011 | $1,121 | 55.8% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 11 | 12 | $1,608 | $860.00 | 53.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 30 | 31 | $2,325 | $520.80 | 22.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 49 | 49 | $1,715 | $380.73 | 22.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 36 | 36 | $1,692 | $380.16 | 22.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 19 | 19 | $836.00 | $184.49 | 22.1% |
| 87086 | Bacterial colony count, urine | Office | 2021 | 18 | 20 | $740.00 | $161.40 | 21.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $600.00 | $123.20 | 20.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 22 | 25 | $375.00 | $79.25 | 21.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 26 | 26 | $390.00 | $58.50 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 100 | $19,200 | $7,158 | 37.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 54 | $7,074 | $3,277 | 46.3% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2020 | 16 | 16 | $2,144 | $1,600 | 74.6% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 19 | $1,447 | $1,134 | 78.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 38 | 38 | $1,786 | $391.82 | 21.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 20 | 21 | $1,575 | $350.42 | 22.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 20 | 20 | $780.00 | $340.04 | 43.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 39 | 40 | $1,400 | $308.56 | 22.0% |
| 87086 | Bacterial colony count, urine | Office | 2020 | 12 | 13 | $481.00 | $104.27 | 21.7% |
About Dr. Robert Meyerson, MD
Dr. Robert Meyerson, MD is a Family Medicine healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629084983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Meyerson, MD has received a total of $719.82 in payments from pharmaceutical and medical device companies, with $431.91 received in 2024. These payments were reported across 14 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($719.82).
As a Medicare-enrolled provider, Meyerson has provided services to 779 Medicare beneficiaries, totaling 811 services with total Medicare billing of $30,688. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Panorama City, CA
- Active Since 07/31/2006
- Last Updated 06/03/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629084983
Products in Payments
- Otezla (Drug) $121.88
- MOUNJARO (Drug) $121.50
- BREZTRI (Drug) $119.83
- FARXIGA (Drug) $119.83
- NEXPLANON (Drug) $47.73
- Proclaim Family of SCS IPGs (Device) $46.50
- TRELEGY ELLIPTA (Drug) $34.50
- JARDIANCE (Drug) $23.84
- AREXVY (Drug) $19.62
- GARDASIL 9 (Biological) $17.61
- Doc Band (Device) $17.39
- STEGLATRO (Drug) $12.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Panorama City
Mrs. Shovek Boyadjian
Family Medicine — Payments: $11,818
Family Medicine $11,818
Reyadh Michail, M.d, M.D
Family Medicine — Payments: $9,576
Family Medicine $9,576
Jose Elacion, M.d, M.D
Family Medicine — Payments: $1,953
Family Medicine $1,953
Nana Barseghian, Md, MD
Family Medicine — Payments: $1,617
Family Medicine $1,617
Heidi Pang, Do, DO
Family Medicine — Payments: $1,230
Family Medicine $1,230
Dr. Arash Karimi Afshar, Do, DO
Family Medicine — Payments: $744.10
Family Medicine $744.10